Last updated on December 2018

Assessment of the GORE EXCLUDER Conformable AAA Endoprosthesis (CEXC Device) in the Treatment of Abdominal Aortic Aneurysms


Brief description of study

The purpose of this research study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis when used for the treatment of Abdominal Aortic Aneurysms (AAA).

The GORE® EXCLUDER® Conformable AAA Endoprosthesis is an investigational device that has not yet been approved by the Food and Drug Administration (FDA). The safety and effectiveness of the device is being tested.

 

Clinical Study Identifier: TX217346

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.